Life Sciences & Diagnostics, Healthcare | Mergers & Acquisitions

Neoteryx has been Acquired by Trajan Group

  • TM Capital served as exclusive financial advisor to Neoteryx, LLC in connection with its sale to Trajan Group Holdings Limited (Australian Stock Exchange: TRJ)
  • Neoteryx, based in Southern California, is a global leader in blood microsampling with operations in the U.S. and Europe
  • The Company’s Mitra® devices and proprietary VAMS® technology facilitate more convenient and accurate remote specimen collection, providing better scientific and medical insights
  • Headquartered in Melbourne, Australia, Trajan is a global developer and manufacturer of analytical and life sciences products and devices used in the analysis of biological, food, water and other environmental samples
  • The transaction further enhances Trajan’s vision to accelerate adoption of remote sampling technologies, expand consumer engagement and facilitate personalized data-based healthcare decisions

Client Testimonial

“At Neoteryx we developed innovative technology to transform specimen collection, and our goal was to achieve global commercial scale through a strategic transaction.  TM Capital brought deep industry expertise and relationships to this assignment, and a sharp focus on achieving our objectives.  Our partnership with Trajan is an exciting outcome for the Neoteryx team and our customers as we together leverage micro-sampling to create advanced healthcare solutions.”
- Fasha Mahjoor, Founder & CEO, Neoteryx, LLC